Right to Try 2026: What the UK’s New Clinical Trial Rules Mean for Access to Experimental Treatments
UK clinical trial reforms took effect in April 2026. Learn what they mean for experimental treatments, EAMS, patient safety and disabled people.
MHRA Cracks Down on Advertising for Steroid-based Drug Kenalog
As the MHRA tightens its oversight of Kenalog advertising, it sends a clear message that the promotion of medications must prioritize patient safety above all else. By fostering transparency and accountability in pharmaceutical marketing, regulatory authorities can help safeguard the well-being of individuals who rely on these medications for their health needs.